Contract Manufacturing, General

CPHI Experts Report that Small to Mid-sized US CDMOs Must Invest Now to Benefit from 2025 Contract Funding Surge

April 30, 2024

Key areas to invest include manufacturing process improvements, quality management, and AI.

Alcami: Beyond Expectations

April 29, 2024

Bill Humphries (CEO, Alcami) dives into an overview of Alcami's capabilities and how they value their client's innovations.

SK pharmteco to Ensure Supply of Ferring Pharmaceuticals Gene Therapy

April 27, 2024

SK pharmteco, a CDMO, will manufacture, test, and release Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy from Ferring Pharmaceuticals for treating bladder cancer.

Annex 1 Alignment: Addressing Contamination Control and Assessing Risk

April 17, 2024

At INTERPHEX 2024, Pharmaceutical Technology sat down with Christa Myers of CRB Group and Nadiyra Walker Speight of Fujifilm Diosynth Biotechnologies to discuss implementation of Annex 1.

AES Clean Technology Launches CleanLock Module

April 16, 2024

The airlock solution for cleanrooms offers contamination controls for a highly controlled environment.

Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy

April 05, 2024

Under a collaboration agreement, Lonza will manufacture sabirnetug, Acumen Pharmaceuticals' mAb in clinical development for treating Alzheimer’s disease.

Taking Full Advantage of Service Providers

April 02, 2024

There are considerations companies may want to consider before seeking out a service provider.

White Raven to Increase Manufacturing Efficiency with Cytiva’s Aseptic Filling Workcell

March 22, 2024

CDMO White Raven aims to reduce contamination risk and gain the capability to handle multiple product formats with the installation of Cytiva’s SA25 Aseptic Filling Workcell.

FDA Greenlights Orchard Therapeutics' Gene Therapy for Children's MLD; AGC Biologics Selected for Manufacturing

March 20, 2024

FDA's approval makes Orchard Therapeutics' Lenmeldy (atidarsagene autotemcel) the first gene therapy approved to treat pediatric metachromatic leukodystrophy in the US.

Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

March 14, 2024

Noramco Group will be an integrated North American-based API and supply chain services provider.